{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:27:37Z","timestamp":1792506457666,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008982","name":"National Science Foundation","doi-asserted-by":"publisher","award":["81672264 and 81871858"],"award-info":[{"award-number":["81672264 and 81871858"]}],"id":[{"id":"10.13039\/501100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10741-021-10158-x","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T17:02:44Z","timestamp":1630170164000},"page":"1431-1441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy"],"prefix":"10.1007","volume":"27","author":[{"given":"Jingmin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-0800","authenticated-orcid":false,"given":"Danyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"issue":"6","key":"10158_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC (2016) Cardiac fibrosis: the fibroblast awakens. Circ Res 118(6):1021\u20131040. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306565","journal-title":"Circ Res"},{"issue":"7","key":"10158_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J (2018) Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 15(7):387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"10158_CR3","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","volume":"136","author":"X Tang","year":"2017","unstructured":"Tang X, Chen XF, Wang NY, Wang XM, Liang ST, Zheng W et al (2017) SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy. Circulation 136(21):2051\u20132067. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028728","journal-title":"Circulation"},{"issue":"8","key":"10158_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C (2018) Metabolic remodelling in heart failure. Nat Rev Cardiol 15(8):457\u2013470. https:\/\/doi.org\/10.1038\/s41569-018-0044-6","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10158_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002416","volume":"9","author":"M Nayor","year":"2016","unstructured":"Nayor M, Enserro DM, Vasan RS, Xanthakis V (2016) Cardiovascular health status and incidence of heart failure in the Framingham offspring study. Circ Heart Fail 9(1):e002416. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002416","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10158_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","volume":"132","author":"RH Oakley","year":"2013","unstructured":"Oakley RH, Cidlowski JA (2013) The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol 132(5):1033\u20131044. https:\/\/doi.org\/10.1016\/j.jaci.2013.09.007","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10158_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1210\/edrv.21.1.0389","volume":"21","author":"RM Sapolsky","year":"2000","unstructured":"Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21(1):55\u201389. https:\/\/doi.org\/10.1210\/edrv.21.1.0389","journal-title":"Endocr Rev"},{"issue":"3","key":"10158_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","volume":"24","author":"JM Busillo","year":"2013","unstructured":"Busillo JM, Cidlowski JA (2013) The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab 24(3):109\u2013119. https:\/\/doi.org\/10.1016\/j.tem.2012.11.005","journal-title":"Trends Endocrinol Metab"},{"issue":"16","key":"10158_CR9","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids\u2013new mechanisms for old drugs. N Engl J Med 353(16):1711\u20131723. https:\/\/doi.org\/10.1056\/NEJMra050541","journal-title":"N Engl J Med"},{"issue":"12","key":"10158_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003432","volume":"17","author":"M Pujades-Rodriguez","year":"2020","unstructured":"Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J (2020) Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study. PLoS Med 17(12):e1003432. https:\/\/doi.org\/10.1371\/journal.pmed.1003432","journal-title":"PLoS Med"},{"key":"10158_CR11","unstructured":"Vedder D, Nurmohamed MT (2021) Increased cardiovascular risk due to glucocorticoids: how strong is the evidence?. Ned Tijdschr Geneeskd 165"},{"key":"10158_CR12","doi-asserted-by":"publisher","unstructured":"Moya FB, Pineda Galindo LF, Garcia de la Pena M (2016) Impact of chronic glucocorticoid treatment on cardiovascular risk profile in patients with systemic lupus erythematosus. J Clin Rheumatol 22(1):8\u201312. https:\/\/doi.org\/10.1097\/RHU.0000000000000335","DOI":"10.1097\/RHU.0000000000000335"},{"issue":"1","key":"10158_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32(1):81\u2013151. https:\/\/doi.org\/10.1210\/er.2010-0013","journal-title":"Endocr Rev"},{"issue":"6","key":"10158_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.coph.2004.09.001","volume":"4","author":"JR Seckl","year":"2004","unstructured":"Seckl JR (2004) 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr Opin Pharmacol 4(6):597\u2013602. https:\/\/doi.org\/10.1016\/j.coph.2004.09.001","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"10158_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1476-5381.2008.00047.x","volume":"156","author":"PW Hadoke","year":"2009","unstructured":"Hadoke PW, Iqbal J, Walker BR (2009) Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. Br J Pharmacol 156(5):689\u2013712. https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00047.x","journal-title":"Br J Pharmacol"},{"issue":"24","key":"10158_CR16","doi-asserted-by":"publisher","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","volume":"111","author":"SA Morgan","year":"2014","unstructured":"Morgan SA, McCabe EL, Gathercole LL, Hassan-Smith ZK, Larner DP, Bujalska IJ et al (2014) 11beta-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci U S A 111(24):E2482\u2013E2491. https:\/\/doi.org\/10.1073\/pnas.1323681111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10158_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1210\/er.2003-0031","volume":"25","author":"JW Tomlinson","year":"2004","unstructured":"Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS et al (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25(5):831\u2013866. https:\/\/doi.org\/10.1210\/er.2003-0031","journal-title":"Endocr Rev"},{"issue":"1","key":"10158_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1570161043476483","volume":"2","author":"S Yang","year":"2004","unstructured":"Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2(1):1\u201312. https:\/\/doi.org\/10.2174\/1570161043476483","journal-title":"Curr Vasc Pharmacol"},{"key":"10158_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2015.03.009","volume":"153","author":"RH Oakley","year":"2015","unstructured":"Oakley RH, Cidlowski JA (2015) Glucocorticoid signaling in the heart: a cardiomyocyte perspective. J Steroid Biochem Mol Biol 153:27\u201334. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.03.009","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10158_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tem.2015.10.001","volume":"27","author":"RV Richardson","year":"2016","unstructured":"Richardson RV, Batchen EJ, Denvir MA, Gray GA, Chapman KE (2016) Cardiac GR and MR: From development to pathology. Trends Endocrinol Metab 27(1):35\u201343. https:\/\/doi.org\/10.1016\/j.tem.2015.10.001","journal-title":"Trends Endocrinol Metab"},{"issue":"4854","key":"10158_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240(4854):889\u2013895. https:\/\/doi.org\/10.1126\/science.3283939","journal-title":"Science"},{"issue":"5\u20137","key":"10158_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.steroids.2005.02.004","volume":"70","author":"Mihailidou AS, Funder JW","year":"2005","unstructured":"Mihailidou AS, Funder JW (2005) Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system. Steroids 70(5\u20137):347\u2013351. https:\/\/doi.org\/10.1016\/j.steroids.2005.02.004","journal-title":"Steroids"},{"issue":"15","key":"10158_CR23","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.4161\/cc.21018","volume":"11","author":"RA Samarasinghe","year":"2012","unstructured":"Samarasinghe RA, Witchell SF, DeFranco DB (2012) Cooperativity and complementarity: synergies in non-classical and classical glucocorticoid signaling. Cell Cycle 11(15):2819\u20132827. https:\/\/doi.org\/10.4161\/cc.21018","journal-title":"Cell Cycle"},{"issue":"1\u20132","key":"10158_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2007.05.018","volume":"275","author":"I Grad","year":"2007","unstructured":"Grad I, Picard D (2007) The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 275(1\u20132):2\u201312. https:\/\/doi.org\/10.1016\/j.mce.2007.05.018","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10158_CR25","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1074\/jbc.R110.179325","volume":"286","author":"RH Oakley","year":"2011","unstructured":"Oakley RH, Cidlowski JA (2011) Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 286(5):3177\u20133184. https:\/\/doi.org\/10.1074\/jbc.R110.179325","journal-title":"J Biol Chem"},{"issue":"2","key":"10158_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cell.2011.03.027","volume":"145","author":"M Surjit","year":"2011","unstructured":"Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D et al (2011) Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145(2):224\u2013241. https:\/\/doi.org\/10.1016\/j.cell.2011.03.027","journal-title":"Cell"},{"issue":"9","key":"10158_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","volume":"34","author":"M Kadmiel","year":"2013","unstructured":"Kadmiel M, Cidlowski JA (2013) Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci 34(9):518\u2013530. https:\/\/doi.org\/10.1016\/j.tips.2013.07.003","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10158_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tem.2004.03.009","volume":"15","author":"A Bhargava","year":"2004","unstructured":"Bhargava A, Pearce D (2004) Mechanisms of mineralocorticoid action: determinants of receptor specificity and actions of regulated gene products. Trends Endocrinol Metab 15(4):147\u2013153. https:\/\/doi.org\/10.1016\/j.tem.2004.03.009","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"10158_CR29","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1210\/en.2010-0237","volume":"151","author":"C Latouche","year":"2010","unstructured":"Latouche C, Sainte-Marie Y, Steenman M, Castro Chaves P, Naray-Fejes-Toth A, Fejes-Toth G et al (2010) Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart. Endocrinology 151(9):4467\u20134476. https:\/\/doi.org\/10.1210\/en.2010-0237","journal-title":"Endocrinology"},{"issue":"3","key":"10158_CR30","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","volume":"93","author":"K Chapman","year":"2013","unstructured":"Chapman K, Holmes M, Seckl J (2013) 11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev 93(3):1139\u20131206. https:\/\/doi.org\/10.1152\/physrev.00020.2012","journal-title":"Physiol Rev"},{"key":"10158_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/IBPC.S13783","volume":"6","author":"Funder JW","year":"2013","unstructured":"Funder JW (2013) Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine. Integr Blood Press Control 6:129\u2013138. https:\/\/doi.org\/10.2147\/IBPC.S13783","journal-title":"Integr Blood Press Control"},{"issue":"5","key":"10158_CR32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.107.098012","volume":"50","author":"Funder JW","year":"2007","unstructured":"Funder JW (2007) Mineralocorticoid receptor activation and oxidative stress. Hypertension 50(5):840\u2013841. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.098012","journal-title":"Hypertension"},{"issue":"4","key":"10158_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.beem.2015.04.007","volume":"29","author":"DW Cain","year":"2015","unstructured":"Cain DW, Cidlowski JA (2015) Specificity and sensitivity of glucocorticoid signaling in health and disease. Best Pract Res Clin Endocrinol Metab 29(4):545\u2013556. https:\/\/doi.org\/10.1016\/j.beem.2015.04.007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10158_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1079\/pns19980017","volume":"57","author":"AL Fowden","year":"1998","unstructured":"Fowden AL, Li J, Forhead AJ (1998) Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc 57(1):113\u2013122. https:\/\/doi.org\/10.1079\/pns19980017","journal-title":"Proc Nutr Soc"},{"issue":"7","key":"10158_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrendo.2014.73","volume":"10","author":"VG Moisiadis","year":"2014","unstructured":"Moisiadis VG, Matthews SG (2014) Glucocorticoids and fetal programming part 1: Outcomes. Nat Rev Endocrinol 10(7):391\u2013402. https:\/\/doi.org\/10.1038\/nrendo.2014.73","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10158_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1203\/00006450-200204000-00006","volume":"51","author":"B Yoder","year":"2002","unstructured":"Yoder B, Martin H, McCurnin DC, Coalson JJ (2002) Impaired urinary cortisol excretion and early cardiopulmonary dysfunction in immature baboons. Pediatr Res 51(4):426\u2013432. https:\/\/doi.org\/10.1203\/00006450-200204000-00006","journal-title":"Pediatr Res"},{"issue":"16","key":"10158_CR37","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1093\/hmg\/ddt182","volume":"22","author":"EA Rog-Zielinska","year":"2013","unstructured":"Rog-Zielinska EA, Thomson A, Kenyon CJ, Brownstein DG, Moran CM, Szumska D et al (2013) Glucocorticoid receptor is required for foetal heart maturation. Hum Mol Genet 22(16):3269\u20133282. https:\/\/doi.org\/10.1093\/hmg\/ddt182","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10158_CR38","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/cdd.2014.181","volume":"22","author":"EA Rog-Zielinska","year":"2015","unstructured":"Rog-Zielinska EA, Craig MA, Manning JR, Richardson RV, Gowans GJ, Dunbar DR et al (2015) Glucocorticoids promote structural and functional maturation of foetal cardiomyocytes: a role for PGC-1alpha. Cell Death Differ 22(7):1106\u20131116. https:\/\/doi.org\/10.1038\/cdd.2014.181","journal-title":"Cell Death Differ"},{"key":"10158_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.mce.2015.07.025","volume":"414","author":"KS Wilson","year":"2015","unstructured":"Wilson KS, Baily J, Tucker CS, Matrone G, Vass S, Moran C et al (2015) Early-life perturbations in glucocorticoid activity impacts on the structure, function and molecular composition of the adult zebrafish (Danio rerio) heart. Mol Cell Endocrinol 414:120\u2013131. https:\/\/doi.org\/10.1016\/j.mce.2015.07.025","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10158_CR40","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1152\/ajplegacy.1968.214.3.518","volume":"214","author":"AM Lefer","year":"1968","unstructured":"Lefer AM (1968) Influence of corticosteroids on mechanical performance of isolated rat papillary muscles. Am J Physiol 214(3):518\u2013524. https:\/\/doi.org\/10.1152\/ajplegacy.1968.214.3.518","journal-title":"Am J Physiol"},{"issue":"3","key":"10158_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0014-2999(71)90091-4","volume":"15","author":"ZJ Penefsky","year":"1971","unstructured":"Penefsky ZJ, Kahn M (1971) Inotropic effects of dexamethasone in mammalian heart muscle. Eur J Pharmacol 15(3):259\u2013266. https:\/\/doi.org\/10.1016\/0014-2999(71)90091-4","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"10158_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/b:mcbi.0000049130.58074.73","volume":"266","author":"N Narayanan","year":"2004","unstructured":"Narayanan N, Yang C, Xu A (2004) Dexamethasone treatment improves sarcoplasmic reticulum function and contractile performance in aged myocardium. Mol Cell Biochem 266(1\u20132):31\u201336. https:\/\/doi.org\/10.1023\/b:mcbi.0000049130.58074.73","journal-title":"Mol Cell Biochem"},{"issue":"5134","key":"10158_CR43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1126\/science.8235594","volume":"262","author":"H Cheng","year":"1993","unstructured":"Cheng H, Lederer WJ, Cannell MB (1993) Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262(5134):740\u2013744. https:\/\/doi.org\/10.1126\/science.8235594","journal-title":"Science"},{"issue":"42","key":"10158_CR44","doi-asserted-by":"publisher","first-page":"17035","DOI":"10.1073\/pnas.1302546110","volume":"110","author":"RH Oakley","year":"2013","unstructured":"Oakley RH, Ren R, Cruz-Topete D, Bird GS, Myers PH, Boyle MC et al (2013) Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease. Proc Natl Acad Sci U S A 110(42):17035\u201317040. https:\/\/doi.org\/10.1073\/pnas.1302546110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10158_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1515\/HMBCI.2010.051","volume":"4","author":"R Ren","year":"2010","unstructured":"Ren R, Cidlowski JA (2010) Glucocorticoid signaling in cardiac disease. Horm Mol Biol Clin Investig 4(2):559\u2013564. https:\/\/doi.org\/10.1515\/HMBCI.2010.051","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"13","key":"10158_CR46","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1161\/01.CIR.0000160352.58142.06","volume":"111","author":"T Aoyama","year":"2005","unstructured":"Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A (2005) Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation 111(13):1652\u20131659. https:\/\/doi.org\/10.1161\/01.CIR.0000160352.58142.06","journal-title":"Circulation"},{"issue":"11","key":"10158_CR47","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1210\/en.2012-1563","volume":"153","author":"R Ren","year":"2012","unstructured":"Ren R, Oakley RH, Cruz-Topete D, Cidlowski JA (2012) Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology 153(11):5346\u20135360. https:\/\/doi.org\/10.1210\/en.2012-1563","journal-title":"Endocrinology"},{"issue":"37","key":"10158_CR48","doi-asserted-by":"publisher","first-page":"19374","DOI":"10.1074\/jbc.M116.725903","volume":"291","author":"D Cruz-Topete","year":"2016","unstructured":"Cruz-Topete D, He B, Xu X, Cidlowski JA (2016) Kruppel-like factor 13 is a major mediator of glucocorticoid receptor signaling in cardiomyocytes and protects these cells from DNA damage and death. J Biol Chem 291(37):19374\u201319386. https:\/\/doi.org\/10.1074\/jbc.M116.725903","journal-title":"J Biol Chem"},{"key":"10158_CR49","doi-asserted-by":"publisher","unstructured":"Pearl JM, Nelson DP, Schwartz SM, Wagner CJ, Bauer SM, Setser EA et al (2002) Glucocorticoids reduce ischemia-reperfusion-induced myocardial apoptosis in immature hearts. Ann Thorac Surg 74(3):830\u20136; discussion 6\u20137. https:\/\/doi.org\/10.1016\/s0003-4975(02)03843-2","DOI":"10.1016\/s0003-4975(02)03843-2"},{"issue":"4","key":"10158_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.004569","volume":"9","author":"A Frustaci","year":"2016","unstructured":"Frustaci A, Letizia C, Verardo R, Grande C, Petramala L, Russo MA et al (2016) Cushing syndrome cardiomyopathy: clinicopathologic impact of cortisol normalization. Circ Cardiovasc Imaging 9(4):e004569. https:\/\/doi.org\/10.1161\/CIRCIMAGING.116.004569","journal-title":"Circ Cardiovasc Imaging"},{"issue":"17","key":"10158_CR51","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/0002-9149(92)90904-d","volume":"69","author":"N Sugihara","year":"1992","unstructured":"Sugihara N, Shimizu M, Kita Y, Shimizu K, Ino H, Miyamori I et al (1992) Cardiac characteristics and postoperative courses in Cushing\u2019s syndrome. Am J Cardiol 69(17):1475\u20131480. https:\/\/doi.org\/10.1016\/0002-9149(92)90904-d","journal-title":"Am J Cardiol"},{"issue":"12","key":"10158_CR52","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/s0735-1097(03)00493-5","volume":"41","author":"ML Muiesan","year":"2003","unstructured":"Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M et al (2003) Left ventricular structural and functional characteristics in Cushing\u2019s syndrome. J Am Coll Cardiol 41(12):2275\u20132279. https:\/\/doi.org\/10.1016\/s0735-1097(03)00493-5","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10158_CR53","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1530\/JME-18-0077","volume":"61","author":"EJ Agnew","year":"2018","unstructured":"Agnew EJ, Ivy JR, Stock SJ, Chapman KE (2018) Glucocorticoids, antenatal corticosteroid therapy and fetal heart maturation. J Mol Endocrinol 61(1):R61\u2013R73. https:\/\/doi.org\/10.1530\/JME-18-0077","journal-title":"J Mol Endocrinol"},{"key":"10158_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/930591","volume":"2012","author":"E Asztalos","year":"2012","unstructured":"Asztalos E (2012) Antenatal corticosteroids: a risk factor for the development of chronic disease. J Nutr Metab 2012:930591. https:\/\/doi.org\/10.1155\/2012\/930591","journal-title":"J Nutr Metab"},{"key":"10158_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.steroids.2016.05.012","volume":"114","author":"R Carson","year":"2016","unstructured":"Carson R, Monaghan-Nichols AP, DeFranco DB, Rudine AC (2016) Effects of antenatal glucocorticoids on the developing brain. Steroids 114:25\u201332. https:\/\/doi.org\/10.1016\/j.steroids.2016.05.012","journal-title":"Steroids"},{"issue":"11","key":"10158_CR56","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1210\/jcem.86.11.7925","volume":"86","author":"Young MJ, Clyne CD, Cole TJ, Funder JW","year":"2001","unstructured":"Young MJ, Clyne CD, Cole TJ, Funder JW (2001) Cardiac steroidogenesis in the normal and failing heart. J Clin Endocrinol Metab 86(11):5121\u20135126. https:\/\/doi.org\/10.1210\/jcem.86.11.7925","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"10158_CR57","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1161\/01.CIR.0000143072.36782.51","volume":"110","author":"S Nakamura","year":"2004","unstructured":"Nakamura S, Yoshimura M, Nakayama M, Ito T, Mizuno Y, Harada E et al (2004) Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart. Circulation 110(13):1787\u20131793. https:\/\/doi.org\/10.1161\/01.CIR.0000143072.36782.51","journal-title":"Circulation"},{"issue":"2","key":"10158_CR58","doi-asserted-by":"publisher","first-page":"R946","DOI":"10.1152\/ajpregu.00402.2006","volume":"292","author":"T Ohtani","year":"2007","unstructured":"Ohtani T, Ohta M, Yamamoto K, Mano T, Sakata Y, Nishio M et al (2007) Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker. Am J Physiol Regul Integr Comp Physiol 292(2):R946\u2013R954. https:\/\/doi.org\/10.1152\/ajpregu.00402.2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10158_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijchv.2014.03.001","volume":"3","author":"D Katoh","year":"2014","unstructured":"Katoh D, Hongo K, Ito K, Yoshino T, Kayama Y, Kawai M et al (2014) Corticosteroids increase intracellular free sodium ion concentration via glucocorticoid receptor pathway in cultured neonatal rat cardiomyocytes. Int J Cardiol Heart Vessel 3:49\u201356. https:\/\/doi.org\/10.1016\/j.ijchv.2014.03.001","journal-title":"Int J Cardiol Heart Vessel"},{"issue":"3","key":"10158_CR60","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cardiores.2006.02.010","volume":"70","author":"K Lister","year":"2006","unstructured":"Lister K, Autelitano DJ, Jenkins A, Hannan RD, Sheppard KE (2006) Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Cardiovasc Res 70(3):555\u2013565. https:\/\/doi.org\/10.1016\/j.cardiores.2006.02.010","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10158_CR61","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/en.2009-1375","volume":"151","author":"MF Rossier","year":"2010","unstructured":"Rossier MF, Python M, Maturana AD (2010) Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes. Endocrinology 151(6):2777\u20132787. https:\/\/doi.org\/10.1210\/en.2009-1375","journal-title":"Endocrinology"},{"issue":"6","key":"10158_CR62","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011484","volume":"8","author":"E Severinova","year":"2019","unstructured":"Severinova E, Alikunju S, Deng W, Dhawan P, Sayed N, Sayed D (2019) Glucocorticoid Receptor-Binding and Transcriptome Signature in Cardiomyocytes. J Am Heart Assoc 8(6):e011484. https:\/\/doi.org\/10.1161\/JAHA.118.011484","journal-title":"J Am Heart Assoc"},{"key":"10158_CR63","doi-asserted-by":"publisher","unstructured":"Sainte-Marie Y, Nguyen Dinh Cat A, Perrier R, Mangin L, Soukaseum C, Peuchmaur M et al (2007) Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block. FASEB J 21(12):3133\u201341. https:\/\/doi.org\/10.1096\/fj.07-8357com","DOI":"10.1096\/fj.07-8357com"},{"issue":"13","key":"10158_CR64","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1101\/gad.9.13.1608","volume":"9","author":"TJ Cole","year":"1995","unstructured":"Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A et al (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9(13):1608\u20131621. https:\/\/doi.org\/10.1101\/gad.9.13.1608","journal-title":"Genes Dev"},{"issue":"3","key":"10158_CR65","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1530\/joe-16-0458","volume":"232","author":"RV Richardson","year":"2017","unstructured":"Richardson RV, Batchen EJ, Thomson AJ, Darroch R, Pan X, Rog-Zielinska EA et al (2017) Glucocorticoid receptor alters isovolumetric contraction and restrains cardiac fibrosis. J Endocrinol 232(3):437\u2013450. https:\/\/doi.org\/10.1530\/joe-16-0458","journal-title":"J Endocrinol"},{"issue":"15","key":"10158_CR66","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011012","volume":"8","author":"D Cruz-Topete","year":"2019","unstructured":"Cruz-Topete D, Oakley RH, Carroll NG, He B, Myers PH, Xu X et al (2019) Deletion of the cardiomyocyte glucocorticoid receptor leads to sexually dimorphic changes in cardiac gene expression and progression to heart failure. J Am Heart Assoc 8(15):e011012. https:\/\/doi.org\/10.1161\/JAHA.118.011012","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10158_CR67","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","volume":"155","author":"VK Arora","year":"2013","unstructured":"Arora VK, Schenkein E, Murali R, Subudhi SK, Wongvipat J, Balbas MD et al (2013) Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155(6):1309\u20131322. https:\/\/doi.org\/10.1016\/j.cell.2013.11.012","journal-title":"Cell"},{"key":"10158_CR68","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.yjmcc.2019.03.019","volume":"130","author":"T Matsuhashi","year":"2019","unstructured":"Matsuhashi T, Endo J, Katsumata Y, Yamamoto T, Shimizu N, Yoshikawa N et al (2019) Pressure overload inhibits glucocorticoid receptor transcriptional activity in cardiomyocytes and promotes pathological cardiac hypertrophy. J Mol Cell Cardiol 130:122\u2013130. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.03.019","journal-title":"J Mol Cell Cardiol"},{"issue":"32","key":"10158_CR69","doi-asserted-by":"publisher","first-page":"30245","DOI":"10.1074\/jbc.M102174200","volume":"276","author":"Q Liang","year":"2001","unstructured":"Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, Molkentin JD (2001) The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276(32):30245\u201330253. https:\/\/doi.org\/10.1074\/jbc.M102174200","journal-title":"J Biol Chem"},{"issue":"4","key":"10158_CR70","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.105.608968","volume":"114","author":"RJ van Oort","year":"2006","unstructured":"van Oort RJ, van Rooij E, Bourajjaj M, Schimmel J, Jansen MA, van der Nagel R et al (2006) MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation 114(4):298\u2013308. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.608968","journal-title":"Circulation"},{"key":"10158_CR71","doi-asserted-by":"publisher","unstructured":"Ouvrard-Pascaud A, Sainte-Marie Y, Benitah JP, Perrier R, Soukaseum C, Nguyen Dinh Cat A et al (2005) Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation\u00a0111(23):3025\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.503706","DOI":"10.1161\/CIRCULATIONAHA.104.503706"},{"issue":"4","key":"10158_CR72","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.110.983023","volume":"123","author":"D Fraccarollo","year":"2011","unstructured":"Fraccarollo D, Berger S, Galuppo P, Kneitz S, Hein L, Schutz G et al (2011) Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 123(4):400\u2013408. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.983023","journal-title":"Circulation"},{"issue":"4","key":"10158_CR73","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.110.163287","volume":"57","author":"A Lother","year":"2011","unstructured":"Lother A, Berger S, Gilsbach R, Rosner S, Ecke A, Barreto F et al (2011) Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function. Hypertension 57(4):746\u2013754. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.163287","journal-title":"Hypertension"},{"issue":"6","key":"10158_CR74","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1161\/HYPERTENSIONAHA.112.203158","volume":"60","author":"AJ Rickard","year":"2012","unstructured":"Rickard AJ, Morgan J, Bienvenu LA, Fletcher EK, Cranston GA, Shen JZ et al (2012) Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone\/salt-mediated inflammation and cardiac fibrosis. Hypertension 60(6):1443\u20131450. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.203158","journal-title":"Hypertension"},{"key":"10158_CR75","doi-asserted-by":"publisher","unstructured":"Oakley RH, Cruz-Topete D, He B, Foley JF, Myers PH, Xu X et al (2019) Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice. Sci Signal 12(577). https:\/\/doi.org\/10.1126\/scisignal.aau9685","DOI":"10.1126\/scisignal.aau9685"},{"issue":"1","key":"10158_CR76","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","volume":"93","author":"W Qin","year":"2003","unstructured":"Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ et al (2003) Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 93(1):69\u201376. https:\/\/doi.org\/10.1161\/01.RES.0000080521.15238.E5","journal-title":"Circ Res"},{"issue":"2","key":"10158_CR77","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.111.185520","volume":"59","author":"M Nagase","year":"2012","unstructured":"Nagase M, Ayuzawa N, Kawarazaki W, Ishizawa K, Ueda K, Yoshida S et al (2012) Oxidative stress causes mineralocorticoid receptor activation in rat cardiomyocytes: role of small GTPase Rac1. Hypertension 59(2):500\u2013506. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.185520","journal-title":"Hypertension"},{"issue":"2","key":"10158_CR78","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","volume":"53","author":"Funder JW","year":"2009","unstructured":"Funder JW (2009) Reconsidering the roles of the mineralocorticoid receptor. Hypertension 53(2):286\u2013290. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.119966","journal-title":"Hypertension"},{"issue":"6","key":"10158_CR79","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","volume":"54","author":"Mihailidou AS, Loan Le TY, Mardini M, Funder JW","year":"2009","unstructured":"Mihailidou AS, Loan Le TY, Mardini M, Funder JW (2009) Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54(6):1306\u20131312. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.136242","journal-title":"Hypertension"},{"key":"10158_CR80","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.yjmcc.2018.10.002","volume":"125","author":"M Huang","year":"2018","unstructured":"Huang M, Liu J, Sheng Y, Lv Y, Yu J, Qi H et al (2018) 11beta-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy. J Mol Cell Cardiol 125:106\u2013116. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.002","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10158_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092869","volume":"9","author":"O Gordon","year":"2014","unstructured":"Gordon O, He Z, Gilon D, Gruener S, Pietranico-Cole S, Oppenheim A et al (2014) A transgenic platform for testing drugs intended for reversal of cardiac remodeling identifies a novel 11betaHSD1 inhibitor rescuing hypertrophy independently of re-vascularization. PLoS ONE 9(3):e92869. https:\/\/doi.org\/10.1371\/journal.pone.0092869","journal-title":"PLoS ONE"},{"issue":"1","key":"10158_CR82","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1210\/en.2015-1630","volume":"157","author":"CI White","year":"2016","unstructured":"White CI, Jansen MA, McGregor K, Mylonas KJ, Richardson RV, Thomson A et al (2016) Cardiomyocyte and vascular smooth muscle-independent 11beta-hydroxysteroid dehydrogenase 1 amplifies infarct expansion, hypertrophy, and the development of heart failure after myocardial infarction in male mice. Endocrinology 157(1):346\u2013357. https:\/\/doi.org\/10.1210\/en.2015-1630","journal-title":"Endocrinology"},{"issue":"6","key":"10158_CR83","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1210\/endo-129-6-3305","volume":"129","author":"BR Walker","year":"1991","unstructured":"Walker BR, Yau JL, Brett LP, Seckl JR, Monder C, Williams BC et al (1991) 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology 129(6):3305\u20133312. https:\/\/doi.org\/10.1210\/endo-129-6-3305","journal-title":"Endocrinology"},{"issue":"6\u20137","key":"10158_CR84","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1440-1681.1996.tb02776.x","volume":"23","author":"RE Smith","year":"1996","unstructured":"Smith RE, Little PJ, Maguire JA, Stein-Oakley AN, Krozowski ZS (1996) Vascular localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme. Clin Exp Pharmacol Physiol 23(6\u20137):549\u2013551. https:\/\/doi.org\/10.1111\/j.1440-1681.1996.tb02776.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10158_CR85","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1210\/jc.2013-2049","volume":"99","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Andrew R, Cruden NL, Kenyon CJ, Hughes KA, Newby DE et al (2014) Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist. J Clin Endocrinol Metab 99(3):915\u2013922. https:\/\/doi.org\/10.1210\/jc.2013-2049","journal-title":"J Clin Endocrinol Metab"},{"key":"10158_CR86","doi-asserted-by":"publisher","unstructured":"Chai W, Hofland J, Jansen PM, Garrelds IM, de Vries R, van den Bogaerdt AJ et al (2010) Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors? J Hypertens 28(5):1044\u201353. https:\/\/doi.org\/10.1097\/HJH.0b013e328335c381","DOI":"10.1097\/HJH.0b013e328335c381"},{"issue":"5","key":"10158_CR87","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/eurheartj\/ehi070","volume":"26","author":"N Glorioso","year":"2005","unstructured":"Glorioso N, Filigheddu F, Parpaglia PP, Soro A, Troffa C, Argiolas G et al (2005) 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. Eur Heart J 26(5):498\u2013504. https:\/\/doi.org\/10.1093\/eurheartj\/ehi070","journal-title":"Eur Heart J"},{"issue":"5","key":"10158_CR88","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI4445","volume":"103","author":"Y Kotelevtsev","year":"1999","unstructured":"Kotelevtsev Y, Brown RW, Fleming S, Kenyon C, Edwards CR, Seckl JR et al (1999) Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J Clin Invest 103(5):683\u2013689. https:\/\/doi.org\/10.1172\/JCI4445","journal-title":"J Clin Invest"},{"issue":"2","key":"10158_CR89","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0889-8529(18)30102-6","volume":"23","author":"BR Walker","year":"1994","unstructured":"Walker BR, Edwards CR (1994) Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin North Am 23(2):359\u2013377","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10158_CR90","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrm.2016.152","volume":"18","author":"ER Weikum","year":"2017","unstructured":"Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR (2017) Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol 18(3):159\u2013174. https:\/\/doi.org\/10.1038\/nrm.2016.152","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10158_CR91","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pharmthera.2016.06.002","volume":"165","author":"JP Hapgood","year":"2016","unstructured":"Hapgood JP, Avenant C, Moliki JM (2016) Glucocorticoid-independent modulation of GR activity: implications for immunotherapy. Pharmacol Ther 165:93\u2013113. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.06.002","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10158_CR92","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.amjcard.2005.08.018","volume":"97","author":"WW Chu","year":"2006","unstructured":"Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pinnow E et al (2006) Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 97(1):34\u201337. https:\/\/doi.org\/10.1016\/j.amjcard.2005.08.018","journal-title":"Am J Cardiol"},{"issue":"1","key":"10158_CR93","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-16-0128","volume":"58","author":"GA Gray","year":"2017","unstructured":"Gray GA, White CI, Castellan RF, McSweeney SJ, Chapman KE (2017) Getting to the heart of intracellular glucocorticoid regeneration: 11beta-HSD1 in the myocardium. J Mol Endocrinol 58(1):R1\u2013R13. https:\/\/doi.org\/10.1530\/JME-16-0128","journal-title":"J Mol Endocrinol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10158-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10158-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10158-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T04:27:38Z","timestamp":1655180858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10158-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10158"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10158-x","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]},"assertion":[{"value":"9 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work; there is no professional or other personal interest of any nature or kind in the manuscript entitled \u201cNew insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}